Budget Amount *help |
¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2013: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2012: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2011: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
Research Abstract |
1) We showed a possible role of glutathione peroxidase1(GPX-1) as a biomakar for early recurrence and metastasis in giant cell tumor of bone (GCTB). Inaddition, overexpression of GPX-1 induced by p53 mutation would have an important role in the malignant transformation of GCTB. 2) We showed that fibroblast growth factor receptor(FGFR4) is a trnascriptional target of EWS-WT1 in desmoplastic small round cell tumor, and FGFR4 and as a possible terapeutic target in this tumor. 3) We showed DDX39 and KCTD10 as biomakars for prognosis in gastrointestinal stromal tumor.
|